| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 11 |
| 1 | ASPIRIN 325 MG | 11 |
| 2 | ASPIRIN 81 MG | 11 |
| 3 | VANCOMYCIN | 11 |
| 4 | VANCOMYCIN HYDROCHLORIDE | 11 |
| 5 | DICLOFENAC | 10 |
| 6 | DICLOFENAC SODIUM | 10 |
| 7 | FENTANYL | 10 |
| 8 | MEROPENEM | 10 |
| 9 | METHOTREXATE SODIUM | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VYJUVEK | 1 | 0.0076 |
| 1 | HYDROCORTISONE ACETATE AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0047 |
| 2 | COLISTIMETHATE SODIUM | 6 | 0.0037 |
| 3 | RIMABOTULINUMTOXINB | 1 | 0.0030 |
| 4 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 1 | 0.0027 |
| 5 | IDARUBICIN HYDROCHLORIDE | 3 | 0.0026 |
| 6 | PRALATREXATE | 1 | 0.0015 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 11 | 0.0013 |
| 8 | DARIFENACIN HYDROBROMIDE | 1 | 0.0012 |
| 9 | CAPSICUM ANNUUM, CETRARIA ISLANDICA, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, THYROIDINUM (SUIS), CADMIUM IODATUM, HYDRANGEA ARBORESCENS, PHOSPHORICUM ACIDUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STRONTIUM CARBONICUM, URANIUM NITRICUM, X-RAY | 1 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 27 |
| 1 | Benzodiazepine [EPC] | 20 |
| 2 | Corticosteroid [EPC] | 14 |
| 3 | Azole Antifungal [EPC] | 13 |
| 4 | Glycopeptide Antibacterial [EPC] | 11 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 11 |
| 6 | Opioid Agonist [EPC] | 11 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 8 | Proton Pump Inhibitor [EPC] | 11 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nitrogen Binding Agent [EPC] | 1 | 0.0004 |
| 1 | Penem Antibacterial [EPC] | 10 | 0.0003 |
| 2 | Oxazolidinone Antibacterial [EPC] | 8 | 0.0003 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | Antiseptic [EPC] | 1 | 0.0002 |
| 5 | Aminoglycoside Antibacterial [EPC] | 9 | 0.0002 |
| 6 | Glycopeptide Antibacterial [EPC] | 11 | 0.0002 |
| 7 | BCL-2 Inhibitor [EPC] | 8 | 0.0001 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |